Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW.

Nature. 1996 Apr 4;380(6573):439-42.

2.

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A.

Nature. 1996 Apr 4;380(6573):435-9.

PMID:
8602241
4.

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.

Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M.

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9349-54.

5.
6.

Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.

Belletti B, Ferraro P, Arra C, Baldassarre G, Bruni P, Staibano S, De Rosa G, Salvatore G, Fusco A, Persico MG, Viglietto G.

Oncogene. 1999 Aug 26;18(34):4860-9.

7.

Vascular endothelial growth factor: possible role in fetal development and placental function.

Cheung CY.

J Soc Gynecol Investig. 1997 Jul-Aug;4(4):169-77. Review.

PMID:
9292845
8.

Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.

Endo T, Kitajima Y, Nishikawa A, Manase K, Shibuya M, Kudo R.

Fertil Steril. 2001 Oct;76(4):762-8.

PMID:
11591411
9.

VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis.

Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M.

Am J Physiol. 1996 May;270(5 Pt 2):H1803-11.

PMID:
8928889
10.

Multiple developmental roles of VEGF suggested by a LacZ-tagged allele.

Miquerol L, Gertsenstein M, Harpal K, Rossant J, Nagy A.

Dev Biol. 1999 Aug 15;212(2):307-22.

11.

Blockade of in vivo VEGF-mediated angiogenesis by antisense gene therapy: role of Flk-1 and Flt-1 receptors.

Marchand GS, Noiseux N, Tanguay JF, Sirois MG.

Am J Physiol Heart Circ Physiol. 2002 Jan;282(1):H194-204.

12.

The splice variants of vascular endothelial growth factor (VEGF) and their receptors.

Robinson CJ, Stringer SE.

J Cell Sci. 2001 Mar;114(Pt 5):853-65. Review.

13.

Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.

Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S.

Princess Takamatsu Symp. 1994;24:162-70. Review.

PMID:
8983073
14.

KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.

Yoshiji H, Kuriyama S, Hicklin DJ, Huber J, Yoshii J, Miyamoto Y, Kawata M, Ikenaka Y, Nakatani T, Tsujinoue H, Fukui H.

Hepatology. 1999 Nov;30(5):1179-86.

PMID:
10534339
15.

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.

Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Büttner M, Rziha HJ, Dehio C.

EMBO J. 1999 Jan 15;18(2):363-74.

17.

Expression of vascular endothelial growth factor and its receptors Flt-1 and KDR/Flk-1 in chronic cyclosporine nephrotoxicity.

Shihab FS, Bennett WM, Yi H, Andoh TF.

Transplantation. 2001 Jul 15;72(1):164-8.

PMID:
11468554
18.

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.

Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A.

Nature. 1994 Feb 10;367(6463):576-9.

PMID:
8107827
19.

VEGF is required for growth and survival in neonatal mice.

Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N.

Development. 1999 Mar;126(6):1149-59.

20.

Signaling pathways induced by vascular endothelial growth factor (review).

Larrivée B, Karsan A.

Int J Mol Med. 2000 May;5(5):447-56. Review.

PMID:
10762646

Supplemental Content

Support Center